A $5.6 million grant helps launch research to improve screening and treatment for a gynecologic disorder disproportionately impacting Black and Hispanic populations.

A large grant for Michigan Medicine will launch important research to improve the screening and treatment for a gynecologic disorder that disproportionately impacts Black and Hispanic populations

Assistant Professor Rachel Niederer of the Department of Biological Chemistry at U-M Medical School is one of the recipients of a collaborative award from the Cystic Fibrosis Foundation.

Assistant Professor Chase Weidmann of the Department of Biological Chemistry at U-M Medical School is the 2024 recipient of the Outstanding Faculty Mentor Award from the CMB Program.

M&I Teresa O'Meara is a recipient of of the Investigators in the Pathogenesis of Infectious Disease (PATH) program of the Burroughs Wellcome Fund. Her lab will further study the mechanisms of attachment and virulence for C. auris, with a focus on how the novel adhesin contributes to pathogenesis. On a practical level, their work will suggest strategies for developing vaccine candidates and therapeutics to limit disease caused by this emerging pathogen.

On May 16, 2024, the Regents of the University of Michigan promoted Melanie Pearson, Ph.D., to Associate Professor on the Research Track, effective September 1, 2024.

Yan Zhang, PhD, Jeanne Stuckey, PhD, Markus Ruetz, PhD, Michael Cianfrocco, PhD, and Wei Cheng, PhD, have been promoted.

The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.

Faith Anderson, Jaime Fuentes, and Andrés Rivera Ruiz, M&I Ph.D. candidates, have been awarded prestigious fellowships from Rackham Graduate School, in recognition of their academic excellence. Congratulations, we’re so proud of you!

A melanoma survivor shares facts and tips about preventing all types of skin cancer.

In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.

Recent research achievements from the Giessen lab.

A study builds on previous work that found depriving T cells of iron prevented cells from proliferating. The current study, published in PNAS, found that excess iron is just as problematic.

Four Graduate Program in Immunology alumni participated in a panel discussion about their career paths.